{
    "2021-09-13": [
        [
            {
                "time": "2018-09-04",
                "original_text": "Regenxbio Stock Catapults To 7-Month High On AbbVie's $1.75 Billion Bet On Gene Therapy",
                "features": {
                    "keywords": [
                        "Regenxbio",
                        "AbbVie",
                        "Gene Therapy",
                        "Collaboration",
                        "7-Month High"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "Why Regenxbio Stock Is Way Up Today",
                "features": {
                    "keywords": [
                        "Regenxbio",
                        "Stock",
                        "Way Up"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "Why Regenxbio Shares Are Trading Higher Today",
                "features": {
                    "keywords": [
                        "Regenxbio",
                        "Shares",
                        "Trading Higher"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "AbbVie Nabs Eye Disease Gene Therapy From Regenxbio for Up to $1.8 Billion",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Regenxbio",
                        "Gene Therapy",
                        "$1.8 Billion"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "AbbVie, RegenXBio Ink $1.75B Retinal Gene Therapy Collaboration",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "RegenXBio",
                        "Gene Therapy",
                        "Collaboration"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "AbbVie's deal to develop Regenxbio's investigational gene therapy could be worth $1.8 billion",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Regenxbio",
                        "Gene Therapy",
                        "Deal"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "UPDATE 1-AbbVie, Regenxbio enter deal to develop retinal disease therapy",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Regenxbio",
                        "Retinal Disease",
                        "Therapy"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "AbbVie and REGENXBIO Announce Eye Care Collaboration",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "REGENXBIO",
                        "Eye Care",
                        "Collaboration"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}